131 related articles for article (PubMed ID: 11710628)
1. Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts.
Yamamoto S; Kurebayashi J; Kurosumi M; Kunisue H; Otsuki T; Tanaka K; Sonoo H
Cancer Chemother Pharmacol; 2001 Oct; 48(4):283-8. PubMed ID: 11710628
[TBL] [Abstract][Full Text] [Related]
2. Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.
Fujimoto-Ouchi K; Tanaka Y; Tominaga T
Clin Cancer Res; 2001 Apr; 7(4):1079-86. PubMed ID: 11309360
[TBL] [Abstract][Full Text] [Related]
3. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
Sawada N; Ishikawa T; Fukase Y; Nishida M; Yoshikubo T; Ishitsuka H
Clin Cancer Res; 1998 Apr; 4(4):1013-9. PubMed ID: 9563897
[TBL] [Abstract][Full Text] [Related]
4. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
[TBL] [Abstract][Full Text] [Related]
5. Changes of gene expression of thymidine phosphorylase, thymidylate synthase, dihydropyrimidine dehydrogenase after the administration of 5'-deoxy-5-fluorouridine, paclitaxel and its combination in human gastric cancer xenografts.
Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Anticancer Res; 2008; 28(3A):1593-602. PubMed ID: 18630517
[TBL] [Abstract][Full Text] [Related]
6. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts.
Sawada N; Ishikawa T; Sekiguchi F; Tanaka Y; Ishitsuka H
Clin Cancer Res; 1999 Oct; 5(10):2948-53. PubMed ID: 10537364
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor activity of UFT and docetaxel on human breast carcinoma xenografts].
Yamada T; Yamada Y; Asanuma F; Kawamura E; Suzuki T
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1725-30. PubMed ID: 11057324
[TBL] [Abstract][Full Text] [Related]
8. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
Ishikawa T; Sekiguchi F; Fukase Y; Sawada N; Ishitsuka H
Cancer Res; 1998 Feb; 58(4):685-90. PubMed ID: 9485021
[TBL] [Abstract][Full Text] [Related]
9. Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.
Nukatsuka M; Fujioka A; Nakagawa F; Oshimo H; Kitazato K; Uchida J; Sugimoto Y; Nagayama S; Fukushima M
Int J Oncol; 2004 Dec; 25(6):1531-6. PubMed ID: 15547687
[TBL] [Abstract][Full Text] [Related]
10. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo.
Takeda Y; Yoshizaki I; Nonaka Y; Yanagie H; Matsuzawa A; Eriguchi M
Anticancer Drugs; 2001 Sep; 12(8):691-8. PubMed ID: 11604557
[TBL] [Abstract][Full Text] [Related]
12. Combination of oral fluoropyrimidine and docetaxel: reappraisal of synergistic effect against gastric carcinoma xenografts.
Kodera Y; Fujiwara M; Yokoyama H; Ohashi N; Miura S; Ito Y; Koike M; Ito K; Nakao A
In Vivo; 2005; 19(5):861-6. PubMed ID: 16097439
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of combinations of anti-HER-2 antibody trastuzumab and oral fluoropyrimidines capecitabine/5'-dFUrd in human breast cancer models.
Fujimoto-Ouchi K; Sekiguchi F; Tanaka Y
Cancer Chemother Pharmacol; 2002 Mar; 49(3):211-6. PubMed ID: 11935213
[TBL] [Abstract][Full Text] [Related]
14. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).
Vanhoefer U; Cao S; Harstrick A; Seeber S; Rustum YM
Ann Oncol; 1997 Dec; 8(12):1221-8. PubMed ID: 9496387
[TBL] [Abstract][Full Text] [Related]
15. [Doxifluridine decreases serum levels of interleukin-6 in a cancer cachexia model].
Yamamoto S; Kurebayashi J; Kunisue H; Udagawa K; Yamamoto Y; Arime I; Tanaka K; Shimozuma K; Sonoo H
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1443-8. PubMed ID: 10500532
[TBL] [Abstract][Full Text] [Related]
16. Effects of introduction of dThdPase cDNA on sensitivity to 5'-deoxy-5-fluorouridine and tumor angiogenesis.
Kim R; Murakami S; Toge T
Int J Oncol; 2003 Apr; 22(4):835-41. PubMed ID: 12632076
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antitumor activity of 5'-deoxy-5-fluorouridine (Furtulon) by taxane in human gastric cancer xenografts.
Sawada N; Nose T; Ishikawa T; Yutaka T
Oncol Rep; 2005 Jul; 14(1):53-7. PubMed ID: 15944767
[TBL] [Abstract][Full Text] [Related]
18. Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.
Hussey HJ; Todorov PT; Field WN; Inagaki N; Tanaka Y; Ishitsuka H; Tisdale MJ
Br J Cancer; 2000 Jul; 83(1):56-62. PubMed ID: 10883668
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of antitumor activity of 5'-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo.
Ikemoto S; Sugimura K; Wada S; Yasumoto R; Yamamoto K; Kishimoto T
Cancer Lett; 1999 Oct; 145(1-2):121-6. PubMed ID: 10530779
[TBL] [Abstract][Full Text] [Related]
20. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
el Kouni MH; el Kouni MM; Naguib FN
Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
